Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies-Reference-Cited by-同舟云学术

Untangling Triple-Negative Breast Cancer Molecular Peculiarity and Chemo-Resistance: Trailing Towards Marker-Based Targeted Therapies

Published:2021-07-26 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Kanwal Bushra

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference38 articles.

1. Cancer statistics, 2020;Siegel RL;CA Cancer J Clin,2020

2. Cancer facts and figures 2021. (2021). https.//www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/20....

3. Triple-negative breast cancer: advancements in characterization and treatment approach;Hurvitz S;Curr Opin Obstet Gynecol,2016

4. Triple negative breast cancer: a brief review of its characteristics and treatment options;Griffiths CL;J Pharm Pract,2012

5. Current and emerging biologic therapies for triple negative breast cancer;Shaikh SS;Expert Opin Biol Ther,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing Nanotechnology‐Based Drug Development for Triple‐Negative Breast Cancer Treatment;Drug and Therapy Development for Triple Negative Breast Cancer;2023-06-16

2. Correlation between the Warburg effect and progression of triple-negative breast cancer;Frontiers in Oncology;2023-01-27

3. The effect of chemotherapy on survival in oldest old patients with nonmetastatic triple negative breast cancer: A populationbased observational study;Journal of Clinical Pharmacy and Therapeutics;2022-09-29

4. Interleukin-6 Signaling in Triple Negative Breast Cancer Cells Elicits the Annexin A1/Formyl Peptide Receptor 1 Axis and Affects the Tumor Microenvironment;Cells;2022-05-20

5. PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients’ CTCs;Cancers;2022-03-29